The industry and its issues, from editor-in-chief Patrick Clinton.
February 1, 2010
By:William Looney
Innovation won't happen until the industry is ready to sit down and make a big change.
 |
January 1, 2010
By:William Looney
Pharma must get its definitions right to be successful in the new decade.
|
December 1, 2009
By:William Looney
The fight against cancer may be the litmus test for how regulation and private investment work together to address the disease burden.
|
November 1, 2009
Despite its success as a proponent of reform, the drug industry, whose main offering is a product easily siloed against other health services, remains vulnerable.
|
October 1, 2009
Governments and payers don't see that innovation covers everything from invention to building market share. Scant attention is paid to the critical "back end" of the innovation cycle.
|
September 1, 2009
Mastery of internal factors can mean the difference between thriving and failing in an environment where industry is a price taker, not a price setter.
|
August 1, 2009
Through innovative patient compliance programs, manufacturers are taking steps to meet the needs of patients and the pharma industry.
|
July 1, 2009
By:Patrick Clinton
In the long run, pharma wants to sell health, not just drugs.
|
June 1, 2009
By:Patrick Clinton
FDA slaps down Cheerios and forces pharma companies that use Google to make technical changes no consumer will ever notice. Big whoop.
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
The New Health is the fast-morphing world of biopharma: emerging science, changing technology, rising costs, global regulations. The New Health needs an ally. More at www.quintiles.com/newhealth.
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?